2024
Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV
Miller E, McGinnis K, Edelman E, Feinberg T, Gordon K, Kerns R, Marshall B, Patterson J, McRae M. Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV. AIDS And Behavior 2024, 1-11. PMID: 39264485, DOI: 10.1007/s10461-024-04494-w.Peer-Reviewed Original ResearchMental health classesSubstance use disordersOpioid use disorderHIV statusBuprenorphine initiationVeterans Aging Cohort StudyInitiate buprenorphineMental health diagnosesAging Cohort StudyBuprenorphine treatmentMultiple pain conditionsAssociated with HIV statusInfluence treatment retentionUse disorderTreatment of opioid use disorderHigher comorbidity burdenAge of patientsClinical encountersMental healthHealth diagnosisBlack veteransHealth classesLatent class analysisCohort studyPrescription data
2023
Co-occurring mental health and drug use experiences among Black and Hispanic/Latino sexual and gender diverse individuals
Watson R, Caba A, Layland E, Simon K, Morgan E, Edelman E, Chan P, Eaton L. Co-occurring mental health and drug use experiences among Black and Hispanic/Latino sexual and gender diverse individuals. Journal Of Behavioral Medicine 2023, 46: 986-995. PMID: 37407904, DOI: 10.1007/s10865-023-00433-7.Peer-Reviewed Original ResearchConceptsHispanics/LatinosDrug useMental healthGender diverse individualsHealth disparitiesCo-occurring mental healthPsychological distressElevated depressive symptomsExtra-medical useDrug use frequencyPerson associationsDrug use experienceImportance of interventionsDepressive symptomsDiverse individualsEffective interventionsAssociationHealthInterventionMinority stressorsDistressUse frequencyIndividualsLatinosOpioids